Almost 1 in 10 (8.0%) people diagnosed with liver cancer in England survive their disease for ten years or more, it is predicted (2013-2017). Five-year relative survival for liver cancer is below the European average in England and Scotland but similar to the European average in Wales and Northern Ireland.
For liver cancer, like other cancer sites, survival trends reflect a combination of changes in treatment and stage distribution. These factors themselves can vary by age, sex and deprivation.
Our data hubs below offer an in-depth breakdown of the most up to date cancer statistics.
*These statistics are aimed at supporting health professionals, academics, researchers and media. If you are a patient or carer, you may want to visit our public facing webpages.
Liver cancer (excluding intrahepatic cholangiocarcinoma) five-year survival in England is similar in females and males (2018-2022).
Explore more detailed gender stats on our data hub for liver cancer
More than 4 in 10 (44.1%) people in England aged 15-44 diagnosed with liver cancer (excluding intrahepatic cholangiocarcinoma) survive their disease for five years or more, compared with 1 in 10 (10%) people aged 75-99 (2018-2022).
Explore more detailed age stats on our data hub for liver cancer
Around 3 in 20 (16.3%) people diagnosed with liver cancer (excluding intrahepatic cholangiocarcinoma) in the most deprived group in England survive their disease for five years or more, compared with around 1 in 5 (21.1%) in the least deprived group (2018-2022).
Explore more detailed deprivation stats on our data hub for liver cancer
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
View full A-Z cancer statisticsFind information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.
Go to local cancer statistics - search profiles by area, constituency or health board in the UK.
You are welcome to reuse this Cancer Research UK content for your own work. When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or follow the link to donate online.
Donate onlineWe are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.
Find out more about the sources which are essential for our statistics
